Skip to content
Screener

Alumis Inc. ALMS Net Income

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.32B+153%
Amgen logo
AmgenAMGN
$2.38B+65.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$53.7M+23.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$36.36M-75.1%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$21.51M-39.4%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$15.15M-21.6%

Segments

By segment

See full
Single Reportable-$142.22M-340%

Other financials

Income statement

See full
Revenue$1.7M-37.7%
Operating income-$148.9M-5.9%
EPS (diluted)-$1.11-244%

Balance sheet

See full
Cash & equivalents$63.7M-58.0%
Total debt$36.4M-6.1%
Total equity$452.2M-6.8%
Total assets$560.6M-8.2%

Cash flow

See full
Operating cash flow-$81.5M+23.4%
CapEx$237.0K-61.5%
Free cash flow-$81.7M+23.6%

Valuation

See full
Market cap$933.23M+126%
Enterprise value$905.95M+136%
P/S126.2×—

Profitability

See full
Operating margin-6,204.4%—
Net margin-5,933.5%—
FCF margin-4,755.3%—

Returns & leverage

See full
Return on equity-93.6%—
Debt / equity0.1×0.0×
Current ratio6.7×+0.7×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Alumis Inc.’s 10-Q, filed August 13, 2026.

Filed
Aug 13, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001847367-26-000018
(in thousands, except share and per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total other income (expense), net4,877191,29910,233193,864
Net income (loss) before income taxes(143,978)50,760(237,031)(48,203)
Income tax benefit1,7578,5611,7578,561
Net income (loss)$(142,221)$59,321$(235,274)$(39,642)
Other comprehensive income (loss):
Unrealized gain (loss) on marketable securities, net(216)30(871)(18)
Total comprehensive income (loss)$(142,437)$59,351$(236,145)$(39,660)
Net income (loss) per share attributable to common stockholders, basic$(1.11)$0.78$(1.86)$(0.61)

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s net income?
Alumis Inc. (ALMS) reported net income of -$142.22M in Q2 2026.
How has Alumis Inc.'s net income changed year-over-year?
Alumis Inc.'s net income decreased by 339.7% year-over-year, from $59.32M to -$142.22M.
What is the long-term trend for Alumis Inc.'s net income?
Over 2 years (2023 to 2025), Alumis Inc.'s net income has grown at a 25.3% compound annual growth rate (CAGR), from -$154.99M to -$243.33M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Alumis Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude